OP-050 Increased Serum Ykl-40 Level is Associated with the Presence and Severity of Metabolic Syndrome - 12/06/16
Doi : 10.1016/j.amjcard.2016.04.090
Mehmet Kadri Akboga 1, Ridvan Yalcin 2, Asife Sahinarslan 2, Canan Yilmaz Demirtas 3, Hatice Pasaoglu 3, Adnan Abaci 2
1 Turkiye Yuksek Ihtisas Training and Research Hospital, Department of Cardiology
2 Gazi University Medical Faculty, Department of Cardiology
3 Gazi University Medical Faculty, Department of Medical Biochemistry
Le texte complet de cet article est disponible en PDF.
Plan
© 2016
Publié par Elsevier Masson SAS.
Vol 117 - N° S1
P. S19-S20 - juin 2016 Retour au numéro
Article précédent
- OP-049 A Novel Marker for Asymptomatic Organ Damage in the Patients with Hypertension: MIR-21
- Erkan Y?ld?r?m, Kamuran Kalkan, Emrah ?pek, U?ur Aksu, Selami Demirelli, Emrah Ermi?, Mustafa Öztürk, Hikmet Hamur
- OP-051 Baroreceptor Activation Therapy with Barostim Neo for Treatment of Resistant Hypertension and/or Heart Failure: First Reported 2 Cases in Turkey
- Sercan Okutucu, Ahmet Baris Durukan, Hasan Alper Gurbuz, Begum Yetis Sayin, Hakan Aksoy, Ebru Ercan Akgul, Cem Yorgancioglu, Ali Oto
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?